Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prianka Singh

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Gastrointestinal Cancer|April 24, 2019
Treatment Patterns and Economic Burden by Lines of Therapy Among Patients with Advanced Hepatocellular Carcinoma Treated with Systemic Cancer TherapyMachaon M Bonafede, Beata Korytowsky, Prianka Singh, et al.
Neuro-Oncology Practice|July 7, 2020
Survival, costs, and health care resource use by line of therapy in US Medicare patients with newly diagnosed glioblastoma: a retrospective observational studyAbdalla Aly, Prianka Singh, Beata Korytowsky, et al.
Journal of Medical Economics|March 31, 2016
Comparison of hospital length of stay and hospitalization costs among patients with non-valvular atrial fibrillation treated with apixaban or warfarin: An early viewLin Xie, Lien Vo, Allison Keshishian, et al.
The American Journal of Managed Care|February 19, 2019
Humanistic and economic burden of hepatocellular carcinoma: systematic literature reviewChristine G Kohn, Prianka Singh, Beata Korytowsky, et al.
Journal of Medical Economics|January 14, 2020
Cost-effectiveness analysis of nivolumab for the treatment of squamous cell carcinoma of the head and neck in the United StatesRobert Haddad, Ezra E W Cohen, Meena Venkatachalam, et al.
Pharmacoeconomics - Open|July 4, 2024
A Cost-Effectiveness Analysis of Adjuvant Nivolumab for Patients with Resected Esophageal Cancer or Gastroesophageal Junction Cancer in FrancePaul Casabianca, Marc Massetti, François-Emery Cotte, et al.
Current Medical Research and Opinion|December 14, 2017
Treatment and discharge patterns among patients hospitalized with non-valvular atrial fibrillation transitioning from the inpatient to outpatient settingHenry J Henk, Feng Cao, Kenneth Tuell, et al.
Journal of Managed Care & Specialty Pharmacy|May 23, 2017
Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care SystemJaeJin An, Fang Niu, Chengyi Zheng, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 18, 2021
Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastomaTrang H Au, Connor Willis, Maija Reblin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 12, 2021
Caregiver burden by treatment and clinical characteristics of patients with glioblastomaTrang H Au, Connor Willis, Maija Reblin, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Gastrointestinal Cancer|April 24, 2019
Treatment Patterns and Economic Burden by Lines of Therapy Among Patients with Advanced Hepatocellular Carcinoma Treated with Systemic Cancer TherapyMachaon M Bonafede, Beata Korytowsky, Prianka Singh, et al.
Neuro-Oncology Practice|July 7, 2020
Survival, costs, and health care resource use by line of therapy in US Medicare patients with newly diagnosed glioblastoma: a retrospective observational studyAbdalla Aly, Prianka Singh, Beata Korytowsky, et al.
Journal of Medical Economics|March 31, 2016
Comparison of hospital length of stay and hospitalization costs among patients with non-valvular atrial fibrillation treated with apixaban or warfarin: An early viewLin Xie, Lien Vo, Allison Keshishian, et al.
The American Journal of Managed Care|February 19, 2019
Humanistic and economic burden of hepatocellular carcinoma: systematic literature reviewChristine G Kohn, Prianka Singh, Beata Korytowsky, et al.
Journal of Medical Economics|January 14, 2020
Cost-effectiveness analysis of nivolumab for the treatment of squamous cell carcinoma of the head and neck in the United StatesRobert Haddad, Ezra E W Cohen, Meena Venkatachalam, et al.
Pharmacoeconomics - Open|July 4, 2024
A Cost-Effectiveness Analysis of Adjuvant Nivolumab for Patients with Resected Esophageal Cancer or Gastroesophageal Junction Cancer in FrancePaul Casabianca, Marc Massetti, François-Emery Cotte, et al.
Current Medical Research and Opinion|December 14, 2017
Treatment and discharge patterns among patients hospitalized with non-valvular atrial fibrillation transitioning from the inpatient to outpatient settingHenry J Henk, Feng Cao, Kenneth Tuell, et al.
Journal of Managed Care & Specialty Pharmacy|May 23, 2017
Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care SystemJaeJin An, Fang Niu, Chengyi Zheng, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 18, 2021
Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastomaTrang H Au, Connor Willis, Maija Reblin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 12, 2021
Caregiver burden by treatment and clinical characteristics of patients with glioblastomaTrang H Au, Connor Willis, Maija Reblin, et al.
Pageof 3